XClose

UCL Institute of Ophthalmology

Home
Menu

DARC Phase II Clinical Trial

We are yet to begin recruitment in Western Eye Hospital

—A Phase 2, open-label, non-randomised, single site, clinical trial of ANX776 in patients diagnosed with:

  • — Primary Open Angle Glaucoma/Glaucoma suspect/Ocular Hypertension (Glaucoma)
  • — Down's syndrome (DS)
  • — Age-Related Macular Degeneration (AMD)
  • — Optic Neuritis (ON)
  • — Healthy subjects (Controls)